These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11956143)

  • 1. Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats.
    Peleg S; Uskokovic M; Ahene A; Vickery B; Avnur Z
    Endocrinology; 2002 May; 143(5):1625-36. PubMed ID: 11956143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3.
    Peleg S; Ismail A; Uskokovic MR; Avnur Z
    J Cell Biochem; 2003 Feb; 88(2):267-73. PubMed ID: 12520525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
    Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
    J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia.
    Sato M; Lu J; Iturria S; Stayrook KR; Burris LL; Zeng QQ; Schmidt A; Barr RJ; Montrose-Rafizadeh C; Bryant HU; Ma YL
    J Bone Miner Res; 2010 Jun; 25(6):1326-36. PubMed ID: 20200930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
    Saito H; Takeda S; Amizuka N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of 1alpha,25-dihydroxyvitamin D3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1alpha,25-dihydroxyvitamin D3 on bone.
    Erben RG; Bromm S; Stangassinger M
    Endocrinology; 1998 Oct; 139(10):4319-28. PubMed ID: 9751515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of Vitamin D analogs on bone formation and resorption.
    Nakane M; Fey TA; Dixon DB; Ma J; Brune ME; Li YC; Wu-Wong JR
    J Steroid Biochem Mol Biol; 2006 Jan; 98(1):72-7. PubMed ID: 16242929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the serum vitamin D binding protein in the actions of the vitamin D analog eldecalcitol (ED-71) on bone and mineral metabolism.
    Brown AJ; Zhang F; Cooke NE; Ritter CS
    Calcif Tissue Int; 2013 Aug; 93(2):163-71. PubMed ID: 23689467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of soy isoflavones and vitamin D3 on bone loss in ovariectomized rats.
    Chang KL; Hu YC; Hsieh BS; Cheng HL; Hsu HW; Huang LW; Su SJ
    Nutrition; 2013 Jan; 29(1):250-7. PubMed ID: 22858193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial.
    DeLuca HF; Bedale W; Binkley N; Gallagher JC; Bolognese M; Peacock M; Aloia J; Clagett-Dame M; Plum L
    J Bone Miner Res; 2011 Mar; 26(3):538-45. PubMed ID: 20890933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fructus ligustri lucidi ethanol extract improves bone mineral density and properties through modulating calcium absorption-related gene expression in kidney and duodenum of growing rats.
    Feng X; Lyu Y; Wu Z; Fang Y; Xu H; Zhao P; Xu Y; Feng H
    Calcif Tissue Int; 2014 Apr; 94(4):433-41. PubMed ID: 24343527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1alpha,25-dihydroxyvitamin D3.
    Erben RG; Mosekilde L; Thomsen JS; Weber K; Stahr K; Leyshon A; Smith SY; Phipps R
    J Bone Miner Res; 2002 Aug; 17(8):1498-511. PubMed ID: 12162504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new active vitamin D analog, ED-71, causes increase in bone mass with preferential effects on bone in osteoporotic patients.
    Kubodera N; Tsuji N; Uchiyama Y; Endo K
    J Cell Biochem; 2003 Feb; 88(2):286-9. PubMed ID: 12520528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
    Srivastava K; Tyagi AM; Khan K; Dixit M; Lahiri S; Kumar A; Changkija B; Khan MP; Nagar GK; Yadav DK; Maurya R; Singh SP; Jain GK; Wahajuddin ; Trivedi R; Chattopadhyay N; Singh D
    Phytomedicine; 2013 Apr; 20(6):470-80. PubMed ID: 23395215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 1α,25-dihydroxyvitamin D
    Wang W; Zhao GD; Cui YJ; Li MQ; Liu ZP
    J Steroid Biochem Mol Biol; 2019 Feb; 186():66-73. PubMed ID: 30253225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.
    Fisher JE; Scott K; Wei N; Zhao JZ; Cusick T; Tijerina M; Karanam B; Duong L; Glantschnig H
    Bone; 2012 Jun; 50(6):1332-42. PubMed ID: 22445539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.